FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

37225411000001101: Empagliflozin 25mg / Linagliptin 5mg tablets 28 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 10-Jul 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
270191000001113 Empagliflozin 25mg / Linagliptin 5mg tablets 28 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
270201000001110 Empagliflozin 25mg / Linagliptin 5mg tablets 28 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Empagliflozin 25mg / Linagliptin 5mg tablets 28 tablet Has VMP Empagliflozin 25mg / Linagliptin 5mg tablets true Inferred relationship Existential restriction modifier
Empagliflozin 25mg / Linagliptin 5mg tablets 28 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Empagliflozin 25mg / Linagliptin 5mg tablets 28 tablet Has specific active ingredient Linagliptin true Inferred relationship Existential restriction modifier
Empagliflozin 25mg / Linagliptin 5mg tablets 28 tablet Has specific active ingredient Empagliflozin true Inferred relationship Existential restriction modifier
Empagliflozin 25mg / Linagliptin 5mg tablets 28 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Empagliflozin 25mg / Linagliptin 5mg tablets 28 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Empagliflozin 25mg / Linagliptin 5mg tablets 28 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Empagliflozin 25mg / Linagliptin 5mg tablets 28 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Glyxambi 25mg/5mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets Is a True Empagliflozin 25mg / Linagliptin 5mg tablets 28 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start